Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

197 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Infectious agents and human malignancies.
Ziegler JL, Buonaguro FM. Ziegler JL, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14:3455-64. doi: 10.2741/3464. Front Biosci (Landmark Ed). 2009. PMID: 19273286 Review.
Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches.
Borrelli A, Bonelli P, Tuccillo FM, Goldfine ID, Evans JL, Buonaguro FM, Mancini A. Borrelli A, et al. Redox Biol. 2018 May;15:467-479. doi: 10.1016/j.redox.2018.01.009. Epub 2018 Feb 3. Redox Biol. 2018. PMID: 29413959 Free PMC article. Review.
Cellular prognostic markers in hepatitis-related hepatocellular carcinoma.
Petrizzo A, Mauriello A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L. Petrizzo A, et al. Infect Agent Cancer. 2018 Mar 27;13:10. doi: 10.1186/s13027-018-0183-8. eCollection 2018. Infect Agent Cancer. 2018. PMID: 29599818 Free PMC article. Review.
Oncolytic virus therapies.
Buonaguro FM, Tornesello ML, Izzo F, Buonaguro L. Buonaguro FM, et al. Pharm Pat Anal. 2012 Nov;1(5):621-7. doi: 10.4155/ppa.12.65. Pharm Pat Anal. 2012. PMID: 24236929 Review.
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.
De Re V, De Zorzi M, Caggiari L, Lauletta G, Tornesello ML, Fognani E, Miorin M, Racanelli V, Quartuccio L, Gragnani L, Russi S, Pavone F, Ghersetti M, Costa EG, Casarin P, Bomben R, Mazzaro C, Basaglia G, Berretta M, Vaccher E, Izzo F, Buonaguro FM, De Vita S, Zignego AL, De Paoli P, Dolcetti R. De Re V, et al. Oncotarget. 2016 Jun 21;7(25):37487-37497. doi: 10.18632/oncotarget.9303. Oncotarget. 2016. PMID: 27183918 Free PMC article.
The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSOD.
Borrelli A, Schiattarella A, Bonelli P, Tuccillo FM, Buonaguro FM, Mancini A. Borrelli A, et al. Biomed Res Int. 2014;2014:476789. doi: 10.1155/2014/476789. Epub 2014 Jan 6. Biomed Res Int. 2014. PMID: 24511533 Free PMC article.
Challenges in cancer vaccine development for hepatocellular carcinoma.
Buonaguro L, Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM. Buonaguro L, et al. J Hepatol. 2013 Oct;59(4):897-903. doi: 10.1016/j.jhep.2013.05.031. Epub 2013 May 25. J Hepatol. 2013. PMID: 23714157 Review.
Immunogenomics approaches for vaccine evaluation.
Petrizzo A, Tornesello M, Buonaguro FM, Buonaguro L. Petrizzo A, et al. J Immunotoxicol. 2012 Jul-Sep;9(3):236-40. doi: 10.3109/1547691X.2012.707698. J Immunotoxicol. 2012. PMID: 22894136 Review.
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
Circelli L, Petrizzo A, Tagliamonte M, Heidenreich R, Tornesello ML, Buonaguro FM, Buonaguro L. Circelli L, et al. Cancer Immunol Immunother. 2017 Jan;66(1):103-112. doi: 10.1007/s00262-016-1923-5. Epub 2016 Nov 10. Cancer Immunol Immunother. 2017. PMID: 27832318
197 results
Jump to page